CA Stock MarketDetailed Quotes

FRX Fennec Pharmaceuticals Inc

Watchlist
  • 8.930
  • +0.020+0.22%
15min DelayMarket Closed Dec 24 13:00 ET
244.97MMarket Cap-165.37P/E (TTM)

About Fennec Pharmaceuticals Inc Company

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Company Profile

SymbolFRX
Company NameFennec Pharmaceuticals Inc
Founded1998
MarketTSE
Employees29
Fiscal Year Ends12-31
Address68 TW Alexander Drive PO Box 13628
CityResearch Triangle Park
CountryUnited States of America
Zip Code27709
Phone+1 919 636-4530

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey S. Hackman
  • Chief Executive Officer and Director
  • --
  • Terry Evans
  • Chief Commercial Officer
  • --
  • Pierre S. Sayad, M.S.
  • Chief Medical Officer
  • --
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 1.31M
  • Christiana Cioffi, M.B.A.
  • Chief Strategy Officer
  • --
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 225.23K
  • Rostislav Raykov
  • Director
  • 2.54M
  • Chris A. Rallis
  • Independent Director
  • 173.18K
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 153.81K
  • Dr. Marco M. Brughera
  • Independent Director
  • 166.31K
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.